Comparison between Rednex Pharmaceuticals IPO and Vivid Electromech IPO.
Rednex Pharmaceuticals IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Vivid Electromech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Rednex Pharmaceuticals IPO | Vivid Electromech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Hem Securities Ltd. | Hem Securities Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | MUFG Intime India Pvt.Ltd. |
| Market Maker | Hem Finlease Pvt.Ltd. | |
| DRHP | DRHP  | DRHP |
| RHP | RHP | |
| Final Prospectus | Final Prospectus | |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL |
The total issue size of Rednex Pharmaceuticals IPO is up to ₹0.00 Cr whereas the issue size of the Vivid Electromech IPO is up to ₹123.94 Cr. The final issue price of Rednex Pharmaceuticals IPO is and of Vivid Electromech IPO is ₹555.00 per share.
| Rednex Pharmaceuticals IPO | Vivid Electromech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹528.00 per share | |
| Issue Price (Upper) | ₹555.00 per share | |
| Issue Price (Final) | ₹555.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 240 shares | |
| Fresh Issue Size | 27,36,000 shares | 17,65,200 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹97.97 Cr |
| OFS Issue Size | 0 shares | 4,68,000 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹25.97 Cr |
| Issue Size Total | 27,36,000 shares | 22,33,200 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹123.94 Cr |
Rednex Pharmaceuticals IPO opens on , while Vivid Electromech IPO opens on Mar 25, 2026. The closing date of Rednex Pharmaceuticals IPO and Vivid Electromech IPO is , and Mar 30, 2026, respectively.
| Rednex Pharmaceuticals IPO | Vivid Electromech IPO | |
|---|---|---|
| Anchor Bid Date | Mar 24, 2026 | |
| Issue Open | Mar 25, 2026 | |
| Issue Close | Mar 30, 2026 | |
| Basis Of Allotment (Tentative) | Apr 02, 2026 | |
| Initiation of Refunds (Tentative) | Apr 06, 2026 | |
| Credit of Share (Tentative) | Apr 06, 2026 | |
| Listing date (Tentative) | Apr 07, 2026 | |
| Anchor Lockin End date 1 | May 02, 2026 | |
| Anchor Lockin End date 2 | Jul 01, 2026 |
Rednex Pharmaceuticals IPO P/E ratio is , as compared to Vivid Electromech IPO P/E ratio of 19.2.
| Rednex Pharmaceuticals IPO | Vivid Electromech IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 99.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 19.2 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹493.27 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 58.10 | 117.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 23.29 | 87.34 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 2.02 | 0.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹28.90 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 45.02 | 73.76 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Rednex Pharmaceuticals IPO Retail Individual Investors (RII) are offered 0 shares while in Vivid Electromech IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in Rednex Pharmaceuticals IPO and 4,46,400 shares in Vivid Electromech IPO.
| Rednex Pharmaceuticals IPO | Vivid Electromech IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 6,68,880 shares |
| Market Maker Reservation | 0 shares | 1,18,800 shares |
| QIB | 0 shares | 4,46,400 shares |
| NII | 0 shares | 3,35,520 shares |
| RII | 0 shares | 7,82,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 22,33,200 shares |
Rednex Pharmaceuticals IPO subscribed in total, whereas Vivid Electromech IPO subscribed 1.06x.
| Rednex Pharmaceuticals IPO | Vivid Electromech IPO | |
|---|---|---|
| QIB (times) | 1.95x | |
| NII (times) | 1.50x | |
| Big NII (times) | 2.10x | |
| Small NII (times) | 0.28x | |
| RII (times) | 0.36x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.06x |
